Sutton Wealth Advisors Inc. Alnylam Pharmaceuticals, Inc. Transaction History

Sutton Wealth Advisors Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2023	SELL	$138.54 - $232.0 $415 - $696	-3 Reduced 37.5%	5 $1 Million
Q1 2022 Nov 07, 2023	BUY	$127.18 - $173.91 $1,017 - $1,391	8 New	8 $1.31 Million
Q2 2019 Nov 06, 2023	SELL	$65.86 - $92.79 $461 - $649	-7 Closed	0 $0
Q1 2019 Nov 06, 2023	SELL	$72.76 - $93.45 $9,749 - $12,522	-134 Reduced 95.04%	7 $654,000
Q4 2018 Nov 06, 2023	BUY	$62.67 - $88.33 $62 - $88	1 Added 0.71%	141 $10.3 Million
Q3 2018 Nov 06, 2023	BUY	$87.52 - $122.67 $262 - $368	3 Added 2.19%	140 $12.3 Million
Q1 2018 Nov 06, 2023	SELL	$115.92 - $148.54 $7,998 - $10,249	-69 Reduced 33.5%	137 $16.3 Million
Q4 2017 Nov 06, 2023	BUY	$114.49 - $139.98 $7,899 - $9,658	69 Added 50.36%	206 $26.2 Million
Q2 2017 Nov 06, 2023	BUY	N/A	25 Added 22.32%	137 $10.9 Million
Q3 2016 Nov 06, 2023	BUY	N/A	112 New	112 $7.59 Million
Q2 2016 Nov 06, 2023	SELL	N/A	-170 Closed	0 $0
Q1 2016 Nov 06, 2023	BUY	N/A	170	170 $10.7 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.